Less Ads, More Data, More Tools Register for FREE

Pin to quick picksM P Evans Regulatory News (MPE)

Share Price Information for M P Evans (MPE)

Share Price is delayed by 15 minutes
Get Live Data
1,502.00    -48.00 (-3.10%)
Bid:
1,494.00
Ask:
1,498.00
Spread: 4.00 (0.268%)
Market Cap: £783.50m
MPE Live PriceLast checked at - London Stock Exchange

Intraday M P Evans Share Chart

Share buyback programme

16 Jun 2022 07:00

RNS Number : 0468P
M. P. Evans Group PLC
16 June 2022
 

M.P. EVANS GROUP PLC

("Group" or "M.P. Evans")

Share buyback programme

The board of directors of MP Evans ("Board") is pleased to announce that it intends to commence a share buyback programme of £2 million ("Programme") from the date of this announcement. All shares acquired under the Programme will be cancelled.

The Board continues to believe that the current share price undervalues the Group's assets, the performance of the business to date and its future prospects. The Group's robust balance sheet provides the opportunity to take advantage of prevailing market conditions to repurchase shares at advantageous levels that will be earnings enhancing.

The Group is undertaking this Programme as part of a disciplined approach to capital allocation, which includes continuing investment across its estates, the ongoing pursuit of strategic acquisition opportunities and payment of dividends at an increased level. The Board sees a case for buybacks being economically attractive since the Group's shares are currently trading below the share price implied by the independent valuation of its assets.

The Programme will operate under the authority granted to the Group by shareholders at the Group's most recent Annual General Meeting, held on 10 June 2022, and within the regulatory limit on the quantity of shares the Group may purchase on any single day. The Programme will be undertaken using a phased approach and have an initial duration of up to 3 calendar months.

The board will keep the programme under review and will make a decision in due course on whether to extend it.

In order to implement the Programme, MP Evans has entered into an agreement with Peel Hunt LLP for them independently to carry out on-market purchases of its 10p shares. The Programme will be conducted in compliance with the Market Abuse Regulation (EU) No. 596/2014 and the delegated regulations made pursuant to it.

16 June 2022

 

Enquiries:

M.P. Evans Group PLC

Telephone: 01892 516333

Peter Hadsley-Chaplin - chairman

Matthew Coulson - chief executive

Peel Hunt LLP (Nomad and joint broker)

Telephone: 020 7418 8900

Dan Webster, Andrew Clark, Lalit Bose

finnCap (Joint broker)

Telephone: 020 7220 0500

Tim Redfern, Harriet Ward

Hudson Sandler (Financial PR)

Telephone: 020 7796 4133

Charlie Jack, Elfie Kent, Francis Kerrigan

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSFAMFTMTTBBPT
Date   Source Headline
23rd Jan 20237:00 amRNSTransaction in Own Shares
20th Jan 20237:00 amRNSTransaction in Own Shares
19th Jan 20237:00 amRNSTransaction in Own Shares
18th Jan 20237:00 amRNSTransaction in Own Shares
17th Jan 20239:10 amRNSDirector/PDMR Shareholding
17th Jan 20237:00 amRNSTransaction in Own Shares
16th Jan 20232:01 pmRNSDirector/PDMR Shareholding
16th Jan 20237:00 amRNSTransaction in Own Shares
16th Jan 20237:00 amRNSCrop and production
13th Jan 20237:00 amRNSTransaction in Own Shares
12th Jan 20237:00 amRNSTransaction in Own Shares
10th Jan 20237:00 amRNSTransaction in Own Shares
9th Jan 20237:00 amRNSTransaction in Own Shares
6th Jan 20234:53 pmRNSDirector/PDMR Shareholding
6th Jan 20237:00 amRNSTransaction in Own Shares
5th Jan 20237:00 amRNSTransaction in Own Shares
4th Jan 20237:00 amRNSTransaction in Own Shares
3rd Jan 20233:52 pmRNSBlock listing Interim Review
3rd Jan 202312:08 pmRNSTotal Voting Rights
3rd Jan 20237:00 amRNSTransaction in Own Shares
30th Dec 20227:00 amRNSTransaction in Own Shares
29th Dec 20227:00 amRNSTransaction in Own Shares
28th Dec 20227:00 amRNSTransaction in Own Shares
22nd Dec 20221:07 pmRNSTransaction in Own Shares
22nd Dec 20227:00 amRNSTransaction in Own Shares
21st Dec 20227:00 amRNSTransaction in Own Shares
19th Dec 20227:00 amRNSShare buyback extension
14th Dec 20227:00 amRNSDirector/PDMR Shareholding
12th Dec 20227:00 amRNSTransaction in Own Shares
9th Dec 20227:00 amRNSTransaction in Own Shares
8th Dec 20227:00 amRNSTransaction in Own Shares
7th Dec 20224:17 pmRNSTR1:Standard form - notification of major holdings
1st Dec 20224:40 pmRNSTotal Voting Rights
29th Nov 20227:00 amRNSTransaction in Own Shares
28th Nov 20227:00 amRNSTransaction in Own Shares
25th Nov 20227:00 amRNSTransaction in Own Shares
23rd Nov 20227:00 amRNSTransaction in Own Shares
21st Nov 20227:00 amRNSTransaction in Own Shares
18th Nov 20227:00 amRNSTransaction in Own Shares
16th Nov 20227:00 amRNSTransaction in Own Shares
11th Nov 20227:00 amRNSTransaction in Own Shares
8th Nov 20227:00 amRNSTransaction in Own Shares
4th Nov 20227:00 amRNSTransaction in Own Shares
3rd Nov 20227:00 amRNSTransaction in Own Shares
2nd Nov 20227:00 amRNSTransaction in Own Shares
1st Nov 20224:45 pmRNSTotal Voting Rights
31st Oct 20227:00 amRNSTransaction in Own Shares
28th Oct 20227:00 amRNSTransaction in Own Shares
26th Oct 20227:00 amRNSTransaction in Own Shares
24th Oct 20227:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.